Evidence map›Paper›PMID 41497631›Full record

ArticlebioRxiv : the preprint server for biology2025

Profiling miRNAs involved in Human Oligodendrocyte Precursor Cell Differentiation and Maturation.

Mansoureh Barzegar, Asmita Dhukhwa, Vaidehi Nilesh Patel, Fernanda C Velasquez, Samarjit Das, Arun H Patil, Marc K Halushka, Donald J Zack, Xitiz Chamling

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Mansoureh BarzegarDepartment of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Asmita DhukhwaDepartment of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Vaidehi Nilesh PatelDepartment of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Fernanda C VelasquezDepartment of Anesthesiology and Critical Care Medicine Johns Hopkins School of Medicine, Baltimore, MD, USA.
Samarjit DasDepartment of Anesthesiology and Critical Care Medicine Johns Hopkins School of Medicine, Baltimore, MD, USA.
Arun H PatilLieber Institute for Brain Development, The Johns Hopkins University, Baltimore, MD, USA.
Marc K HalushkaDepartmhent of Pathology, Cleveland Clinic, Cleveland, OH, USA.
Donald J ZackDepartment of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Xitiz ChamlingDepartment of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, MD, USA.ORCID 0000-0001-6401-7715

Funding

Developing Remyelination Strategies for Demyelinating Optic Neuropathies Using Human Pluripotent Stem CellsR00EY029011 · NEI · JOHNS HOPKINS UNIVERSITY · PI CHAMLING, XITIZ · 2022 to 2024
$731k
NEI NIH HHS R00 EY029011
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are evolutionarily conserved post-transcriptional regulators that play critical roles in cellular development and differentiation across species. Although the importance of miRNAs in oligodendrocyte lineage cell (OLLC) differentiation has been extensively studied in rodent models, their roles in human OL development remain less understood. To address this gap, we used a human embryonic stem cell (hESC) reporter system designed to study human OLs and OL progenitor cells (OPCs). Using an optimized differentiation protocol, we used the reporter hESCs to generate and isolate well-characterized OLLCs at specific developmental stages and performed next-generation sequencing-based miRNA profiling to identify stage-specific miRNAs enriched during OL lineage specification and maturation. In addition to canonical miRNAs known to be enriched at various stages of OL development, our study identified several lesser-known miRNAs with distinct stage-specific enrichment patterns that may serve as useful molecular markers for classifying human CNS cell types in future studies. Target analysis of OPC- and OL-enriched miRNAs revealed key genes, including transcription factors ZNF488 and DLX1, cytoskeletal regulator CSNK2B, and potassium channel gene KCNJ1, along with key signaling pathways such as AKT, SMAD2/3, estrogen receptor, and insulin signaling, which regulate OPC and OL lineage function. These findings advance our understanding of the OLLC-specific miRNAs, and miRNA-mediated regulatory networks governing human OL differentiation and maturation and provide promising therapeutic targets for future studies aimed at restoring myelin integrity and improving outcomes in demyelinating diseases.

Indexed as

human oligodendrocyte progenitor cells (hOPC)human oligodendrocytes differentiation and maturationhuman pluripotent stem cells (hPSCs)microRNAsNGS

Identifiers

PMID41497631
PMCPMC12767315

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.